Bridgeway Capital Management, LLC Pfizer Inc Transaction History

Bridgeway Capital Management, LLC

$4.76 Billion
Q1 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 680,662 shares of PFE stock, worth $19 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

680,662

Previous 466,252 45.99%

Holding current value

$19 Million

Previous $13.4 Million 40.71%

% of portfolio

0.4%

Previous 0.29%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $5.55 Million - $6.37 Million	214,410 Added 45.99%	680,662 $18.9 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $2.51 Million - $3.26 Million	96,185 Added 25.99%	466,252 $13.4 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $906,735 - $1.06 Million	28,256 Added 8.27%	370,067 $12.3 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $9.79 Million - $11.3 Million	270,999 Added 382.7%	341,811 $12.5 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $334,815 - $435,880	8,500 Added 13.64%	70,812 $2.89 Million

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $6.42 Million - $8.38 Million	-153,812 Reduced 71.17%	62,312 $3.19 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $4.83 Million - $5.89 Million	-110,300 Reduced 33.79%	216,124 $9.46 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $1.34 Million - $1.59 Million	-28,750 Reduced 8.09%	326,424 $17.1 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $8.04 Million - $9.96 Million	175,750 Added 97.95%	355,174 $18.4 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $2.61 Million - $3.86 Million	-63,100 Reduced 26.02%	179,424 $10.6 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $586,787 - $753,779	-14,950 Reduced 5.81%	242,524 $10.4 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $743,336 - $842,076	-20,700 Reduced 7.44%	257,474 $10.1 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $284,665 - $321,045	-8,500 Reduced 2.97%	278,174 $10.1 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $20.8 Million - $26.5 Million	-622,600 Reduced 68.47%	286,674 $10.6 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $19.2 Million - $22.5 Million	-603,300 Reduced 39.89%	909,274 $33.4 Million
Q2 2020 Aug 31, 2020	BUY	$30.12 - $36.54 $753,000 - $913,500	25,000 Added 1.68%	1,512,574 $49.5 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $9.75 Million - $11.8 Million	-323,600 Reduced 17.87%	1,487,574 $48.6 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $9.53 Million - $13.6 Million	-352,650 Reduced 16.3%	1,811,174 $59.1 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $6.82 Million - $7.74 Million	-207,200 Reduced 8.74%	2,163,824 $84.8 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $4.9 Million - $6.35 Million	150,750 Added 6.79%	2,371,024 $85.2 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $2.29 Million - $2.57 Million	-61,800 Reduced 2.71%	2,220,274 $96.2 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $3.89 Million - $4.27 Million	-103,600 Reduced 4.34%	2,282,074 $96.9 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $592,438 - $675,444	-15,400 Reduced 0.64%	2,385,674 $104 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $4.92 Million - $5.97 Million	142,700 Added 6.32%	2,401,074 $106 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $10.6 Million - $11.3 Million	320,900 Added 16.56%	2,258,374 $81.9 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $35,101 - $40,722	-1,100 Reduced 0.06%	1,937,474 $68.8 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $775,623 - $822,962	23,320 Added 1.22%	1,938,574 $70.2 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $59.4 Million - $65.4 Million	1,915,254	1,915,254 $68.4 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Pfizer Inc Transaction History